Search

everythinglearnresearchcommunity

for

Search:↓

The Hair Check tool can measure hair loss, but patients' own reports are more reliable for assessing hair loss during chemotherapy.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

Ginger supplements helped reduce symptoms and improve metabolic health in hypothyroid patients.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

People with polycystic ovary syndrome (PCOS) are more likely to have higher levels of depression and anxiety, but their personality traits are similar to those without PCOS.

Eating vegetarian, having allergies, and family history might be linked to getting gray hair early.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

Metformin improved insulin resistance and BMI in overweight Taiwanese women with PCOS, and a 2-hour insulin test may be a good screening tool.

More than half of the women with PCOS in Southern India had Metabolic Syndrome, with large waist circumference being the most common feature.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

People with cutaneous Lichen Planus are more likely to have Metabolic Syndrome and related conditions like high cholesterol, diabetes, and high blood pressure.

Monofilament Threads significantly improve hair growth in women with pattern hair loss and are safe.

Women with severe frontal fibrosing alopecia are more likely to have rosacea.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Hair steroid measurement is an effective method to diagnose and monitor CAH in developing countries.

People with androgenetic alopecia have a higher risk of metabolic syndrome.

Hair loss reduces hair thickness and coverage, but drug treatments mainly revive dormant hairs rather than reverse thinning; patients often undervalue their hair loss severity.

Polycystic ovary syndrome (PCOS) lowers women's quality of life, especially mentally and socially, but nursing guidelines can improve their understanding of the condition.

New treatment reduces hair shedding and increases hair density in women with early hair loss.

People with PCOS have higher levels of PAI-1, which may increase their risk of heart disease and fertility issues.

The Fatty Liver Index (FLI) may not be enough to rule out non-alcoholic fatty liver disease in lean women with polycystic ovary syndrome.

Unhealthy lifestyle and diet may increase the risk of early hair loss in young men.

Acne in adult women is often linked to polycystic ovary syndrome, especially in those who are younger, have premenstrual acne flare-ups, and irregular periods.

Women with Polycystic Ovary Syndrome (PCOS) have a lower health-related quality of life, especially those with an anovulatory phenotype, and need specific interventions to improve it.

Obese women with PCOS have lower zinc levels than non-obese ones.

Obesity may worsen hair loss in men and increase hirsutism in overweight or obese individuals, with weight loss recommended for treatment.

Women with PCOS and higher BMI, especially those with morbid obesity, are at greater risk for depression.

The Cross-section Trichometer is a promising tool for measuring hair characteristics without cutting the hair and may have various clinical uses.

Some overweight or obese men with long-term frontal fibrosing alopecia may have abnormal sex hormone levels.